Meanwhile at the TCT there have been very dismal results for Boston scientific with their TAVR/TMVR that could present an opportunity for Anteris, perhaps a partnership or a Tissue supply deal, as their TAVR/TMVR dreams have taken a huge setback and will need better tissue and design to stay in the race, anyways here is the podcast:
https://medtech.pharmaintelligence.informa.com/MT142956/Device-Week-23-October-2020--Conference-Spotlight-TCT-HLTH
in case any of you have issues with the link above I have downloaded the mp3 to the link below:
https://mega.nz/file/P80ynBSD#is3R2MukD58_FXVMrIZm16TUY0MT6K9yTennm4FSDwA
thoughts?
New Research Report - MST Access, page-12
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
0.200(1.57%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $12.62 | $12.99 | $12.61 | $210.9K | 16.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1099 | $12.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.98 | 246 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |